Global Companion Diagnostics Market – Scenario

Global Companion Diagnostics Market is expected to grow at a CAGR of 15.4% during forecasted period 2017-2023. Companion Diagnostics is the as a bio-analytical method designed for the assessment of the patient to check whether patient responds to a specific medical treatment or not. Companion diagnostics are used to determine which patients are benefited from a certain type of medication or which therapies are best suited for the patients with certain medical conditions.

Companion diagnostics involves tests and devices or tools which provide information about the safe and effective use of the specific therapeutic product. It not only provides information about the efficacy of the drugs but also the side effects that are associated with the drug.

To control the rising cost of the drug discovery and development for the deadly and chronic diseases, the need for companion diagnostics is increasing; and with the increasing demand for the companion diagnostic tools and techniques, the global market for the companion diagnostics is growing.

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/3077

Among all the regions in the world, the U.S. has been the first choice for a suitable deployment of companion diagnostic solutions due to the availability of established healthcare system and technological advancement.

Moreover, a number of CDx initiatives, research & development programs, product launch and diagnostic tools have emerged and lot many are still in the pipeline. The U.S. has gained significant pharmaceutical developments along with FDA approvals; patents and licensing that enable it to position itself in the global companion diagnostic market.

Top Vendors:

Some of the key players in this market are: Abbott (U.S.), Agilent Technologies (U.S.), ARUP Laboratories (U.S.), F. Hoffmann-La Roche AG. (Germany), Myriad Genetics Inc. (U.S.), QIAGEN N.V. (Germany), and Thermo Fisher Scientific Inc. (U.S.).

Segmentation:

The global companion diagnostics market has been segmented on the basis of technology which comprises of Polymerase chain reaction (PCR), In-situ hybridization, and immunohistochemistry.

On the basis of application, market is segmented into cancer, infectious diseases, cardiovascular diseases, CNS diseases, and others

On the basis of end user, market is segmented into pharmaceutical & biotech companies, clinical laboratories, CRO, and other.

Regional Analysis:

Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.

The North America includes the U.S., and Canada; and presently, they together dominate the global companion diagnostic market. Further, South America comprises of countries such as Brazil, Peru, Columbia, and Panama among others, and they all contribute a very small share in the global companion diagnostic market.

Europe, accounts for the second largest, in the global companion diagnostics market. The European region includes both Western and Eastern European countries which are involved in development of companion diagnostics. The major countries in the Western Europe are Germany, France, UK, Italy, and Spain. These companion diagnostic solutions are increasing the efficiency of the healthcare workforce and systems driven by the increasing adoption of precise diagnostic tools, electronic healthcare records and drugs prescribed particularly for a disease.

Asia-Pacific region is estimated to be the fastest growing market due to continuous developments in developing countries like India and China.

Browse Complete 107 Pages Premium Research Report Enabled with 126 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/companion-diagnostic-market-3077

Major Points of TOC:

1 Report Prologue

2 Market Introduction

3 Research Methodology

4 Market Dynamics

5 Market Factor Analysis

6 Global Companion Diagnostics Market, By Technology

7 Global Companion Diagnostics Market, By Application

8 Global Companion Diagnostics Market, By End User

9 Global Companion Diagnostics Market, By Region

10 Competitive Landscape

11 Company Profile

List of Tables:

TABLE 1 Global COMPANION DIAGNOSTICS MARKET, By Technology, 2014-2023 (USD Million)

TABLE 2 Global PCR Based Companion Diagnostics MARKET, By Region, 2014-2023 (USD Million)

TABLE 3 Global In-Situ Hybridization Based Companion Diagnostics MARKET, By Region, 2014-2023 (USD Million)

TABLE 4 GLOBAL Immunohistochemistry BASED COMPANION DIAGNOSTICS MARKET, BY REGION, 2014-2023 (USD MILLION)

TABLE 5 GLOBAL COMPANION DIAGNOSTICS MARKET, BY Application, 2014-2023 (USD MILLION)

TABLE 6 GLOBAL Companion Diagnostics MARKET For Cancer, BY REGION, 2014-2023 (USD MILLION)

TABLE 7 GLOBAl Companion Diagnostics MARKET For Infectious Diseases, BY REGION, 2014-2023 (USD MILLION)

TABLE 8 GLOBAl Companion Diagnostics MARKET For Cardiovascular Diseases, BY REGION, 2014-2023 (USD MILLION)

TABLE 9 GLOBAl Companion Diagnostics MARKET For CNS Disorders, BY REGION, 2014-2023 (USD MILLION)

TABLE 10 GLOBAL COMPANION DIAGNOSTICS MARKET, BY End User, 2014-2023 (USD MILLION)

LOT CONTINUED…

Check Discount at https://www.marketresearchfuture.com/check-discount/3077

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: [email protected]